ArticleNigerian medical journal : journal of the Nigeria Medical Association
Challenges, Clinical and Laboratory Profile of Children Referred for Micropenis at a Nigerian Tertiary Hospital.
Article in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Micropenis in a child may not only be related to cosmesis but raise the suspicion of a disorder of sex development or endocrine conditions requiring urgent attention. The study aims to describe the clinical and laboratory profile of children referred for micropenis over a six-year period at the Lagos University Teaching Hospital (LUTH) and highlight challenges encountered in management of these children. Methodology: This was a retrospective study. Case records of patients who were referred with complaints or diagnoses of "micropenis" from March 2018 to March 2024 were analysed. The Health Research and Ethics Committee of LUTH approved the study. Results: Eighty-three children were referred for micropenis. On review, the stretched penile length (SPL) in 16 children (mean [SD]age of 8.9± 3.42 years) was within reference ranges and they were excluded from further evaluations. The remaining 67 children with confirmed micropenis constituted 12.4% of 541 new paediatric endocrine cases. The median age (range) at presentation was 9(0.7-16) years. Boys within the peripubertal age group constituted the majority of the patients. Co-morbidities included obesity, Down Syndrome, sickle cell anaemia, and growth hormone deficiency. Challenges in management included unaffordability of laboratory tests as only 21 children (31.3%) performed the human chorionic gonadotrophin (hCG) stimulation, our local testing, more than half (68.6%) could not carry out any investigations and age-appropriate/ preparations of testosterone were unavailable for treatment. Conclusion: Micropenis constituted a sizeable proportion of the paediatric endocrine consultations in our setting. Accurate measurements are important to exclude unaffected children and prevent unnecessary expensive investigations. The National Health Insurance Services (NHIS) should be strengthened to enable patients to access necessary investigations and treatment related to micropenis. Licensing of age-appropriate drugs for treatment by relevant authorities is advocated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.